Definitions.
Oceanside City Code § 20.55.3
in effect20.55.3. - Definitions.
The following words, terms and phrases, when used in this article, shall have the meanings ascribed to them in this section, except where the context clearly indicates a different meaning:
Business shall have the same meaning as the term is defined in article 15, section 15.1.2 of this Code.
Consume, consuming or consumption means to ingest, inhale, inject, smoke, snort (insufflate), or take by anal suppository.
Distribute, distributing or distribution means to furnish, give away, exchange, transfer, deliver or supply, whether for monetary gain or not.
Mislabeled/misbranded product(s) means any synthetic drug, substance that is represented to be a synthetic drug, novel psychoactive substance, or other product containing a psychoactive substance for which:
(1) The label is in any way false or misleading;
(2) The label does not bear the name and place of business of the manufacturer, repackager, or distributor of the finished form of the product;
(3) The label does not bear adequate directions for use; or
(4) The label does not bear adequate warnings against use or the potential effects of consumption.
Novel psychoactive substance means any compound that mimics the effects of any federally controlled schedule I or II substance, including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance, and their analogue (including salts, isomers, esters, ethers, and salts of isomers) containing substances which have a psychedelic, psychotropic, hallucinogenic or other similar effect on the central nervous system and/or brain, including, but not limited to:
(1) 2,5-dimethoxy-amphetamine.
(2) 2,3-dihydro-1H-inden-2-amine.
(3) 2-fluoromethamphetamine.
(4) methoxyketamine.
(5) 2-(4-bromo-2,5-dimethoxyphenyl)ethanamine.
(6) 4-Chloro-2,5-dimethoxyphenethylamine.
(7) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine.
(8) 4-Ethyl-2,5-dimethoxyphenethylamine.
(9) 2-(2,5-Dimethoxyphenyl)ethanamine.
(10) 4-Iodo-2,5-dimethoxyphenethylamine.
(11) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine.
(12) 2,5-Dimethoxy-4-propylphenethylamine.
(13) 2-(2.5-dimethoxy-4-(methylthio)phenyl)ethanamine.
(14) 2-(10-Bromo-2,3,4,7,8,9-hexahydropyrano[2,3-g]chromen-5-yl)ethanamine.
(15) 2-(8-bromo-2,3,6,7-tetrahydrofuro [2,3-f][1]benzofuran-4-yl)ethanamine.
(16) 2-(7-Bromo-5-methoxy-2,3-dihydro-1-benzofuran-4-yl)ethanamine.
(17) N-(2-Methoxybenzyl)-1-(8-bromo-2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b']difuran-4-yl)-2-aminoethane.
(18) 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.
(19) N-(2-methoxybenzyl)-1-[(7R)-3-bromo-2,5-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine.
(20) 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.
(21) 2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.
(22) N-(2-Hydroxybenzyl)-4-iodo-2,5-dimethoxyphenethylamine.
(23) 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.
(24) 2,5-Dimethoxy-4-ethylthiophenethylamine.
(25) 2,5-Dimethoxy-4-isopropylthiophenethylamine.
(26) 2,5-Dimethoxy-4-(n)-propylthiophenethylamine.
(27) 2-(4-trifluoromethyl-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.
(28) 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-fluorophenyl)methyl]ethanamine.
(29) 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2,3-methylenedioxyphenyl)methyl]ethanamine.
(30) 3-[1-(ethylamino)cyclohexyl]phenol.
(31) 3-hydroxyphencyclidine.
(32) 3-Methoxyeticyclidine.
(33) 1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine.
(34) 2-(4-bromo-2,3,6,7-tetrahydrofurobensofuran-8-yl)-1-methyl-ethylamine.
(35) 3-(2-Diethylaminoethyl)-1H-indol-4-yl acetate.
(36) 4-acetoxy-N,N-dimethyltryptamine.
(37) 4-acetoxy-N,N-dipropyltryptamine.
(38) 4-Chlorophenylisobutylamine.
(39) Para-fluoroamphetamine.
(40) 4-fluoromethamphetamine.
(41) 4-Hydroxy-di-isopropyl-tryptamine.
(42) 4-hydroxy-N-methyl-N-ethyltryptamine.
(43) 3-(2-[Isopropyl(methyl)amino]ethyl)-1H-indol-4-ol.
(44) (R)-3-(N-methylpyrrolidin-2-ylmethyl)-4-hydoxyindole.
(45) 3-(2-[methyl(propyl)amino]ethyl)-1H-indol-4-ol.
(46) 4-methoxy-N-methyl-N-isopropyltryptamine.
(47) 4-Methoxyphencyclidine.
(48) 4-Methyl-α-ethyltryptamine.
(49) 4-methyl-a-pyrrolidinohexphenone.
(50) 5-(2-Aminopropyl)benzofuran.
(51) 5-(2-Aminopropyl)-2,3-dihydrobenzofuran.
(52) 5-Iodo-2-aminoindane.
(53) 5-methyl-ethylone.
(54) 1-(5-methoxy-1H-indol-3-yl)propan-2-amine.
(55) N,N-diallyl-5-methoxytryptamine.
(56) N,N-Dethyl-5-Methoxytryptamine.
(57) 5-methoxy-diisopropyltryptamine.
(58) 5-methoxy-N,N-dimethyltryptamine.
(59) N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-propylpropan-1-amine.
(60) N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine.
(61) (R)-3-(N-methylpyrrolidin-2-ylmethyl)-5-methoxyindole.
(62) 6-(2-aminopropyl)benzofuran.
(63) 6-(2-Aminopropyl)-2,3,-dihydrobenzofuran.
(64) ((2-aminopropyl)benzofuran.
(65) ((2-aminopropyl)-2,3-dihydrobenzofuran).
(66) 1-(4-Bromofuro[2,3-f][1]benzofuran-8-yl)propan-2-amine.
(67) Benzothiophenylcyclohexylpiperidine.
(68) N,N-Diisopropyltryptamine.
(69) 1,4-Dibenzylpiperazine.
(70) 1,4-dibenzylpiperazine.
(71) 2,5-Dimethoxy-4-bromoamphetamine.
(72) 2,5-Dimethoxy-4-chloroamphetamine.
(73) 2,5-dimethoxy-4-iodoamphetamine.
(74) N,N-Dipropyltryptamine.
(75) 2-(2-chlorophenyl)-2-(ethylamino)cyclohexanone.
(76) Fluoroamphetamine.
(77) Fluoromethamphetamine.
(78) Para-fluorophenylpiperazine.
(79) 7-hydroxymitragynine.
(80) 1-(3-Chlorophenyl)piperazine.
(81) N-(2-Methoxybenzyl)-2-(3,4,5-trimethoxyphenyl)ethanamine.
(82) 1-(thiophen-2-yl)-2-methylaminopropane.
(83) (RS)2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone.
(84) N-methyltryptamine.
(85) N-isopropyl-N-methyltryptamine.
(86) Methyl-alpha-pyrrolidinohexiophenone.
(87) N,N-dimethylamphetamine.
(88) 3-[2-(1-Amino-1-methylethyl)-1-hydroxycyclohexyl]phenol.
(89) 7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one.
(90) 1-(4-Methoxyphenyl)piperazine.
(91) Para-Methoxy-N-methylamphetamine.
(92) 1-[4-(trifluoromethylphenyl)]piperazine.
(93) 3-trifluoromethylphenylpiperazine.
(94) Kratom; drug "of concern" for the DEA.
Person includes any natural person, proprietor, business, firm, company, corporation, public corporation, club, trust, partnership, association or similar organization.
Possess, possessing or possession means to have a synthetic drug or mislabeled/misbranded product in one's actual or constructive custody or control, or under one's authority or power, whether such custody, control, authority or power be exercised solely or jointly with others.
Provide, providing or provision shall mean offering to distribute, give away, or sell a synthetic drug to any person.
Synthetic cannabinoid (also known as Spice) means:
(1) Any organic product consisting of plant material in granular, loose leaf, powder form, or in liquid or as a food additive, or any herbal-incense-type stimulant or hallucinogen product, that contains a synthetic stimulant compound that, when consumed, elicits psychoactive euphoric effects and
(2) Any laboratory-created compound that functions similar to the active ingredient in marijuana, tetrahydrocannabinol (THC), including, but not limited to, any quantity of natural or synthetic material, compound, mixture, preparation, substance, or their analogue (including isomers, esters, ethers, salts, and salts of isomers) containing a cannabinoid receptor agonist, including, but not limited to, the following:
a. Adamantoylindoles or adamantoylindazoles, including adamantyl carboxamide indoles and adamantyl carboxamide indazoles, or any compound structurally derived from 3-(1-adamantoyl) indole, 3-(1-adamantoyl)indazole, 3-(2-adamantoyl)indole, N-(1-adamantyl)-1H-indole-3-carboxamide, or N-(1-adamantyl)-1H-indazole-3-carboxamide by substitution at the nitrogen atom of the indole or indazole ring with alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole or indazole ring to any extent and whether or not substituted in the adamantyl ring to any extent, including, but not limited to, the following: 2NE1, 5F-AKB-48, AB-001, AKB-48, AM-1248, JWH-018 adamantyl carboxamide, STS-135.
b. Benzoylindoles—any compound structurally derived from a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent, including, but not limited to, the following: AM-630, AM-661, AM-679, AM-694, AM-1241, AM-2233, RCS-4, WIN 48,098 (Pravadoline).
c. Cyclohexylphenols—any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the cyclohexyl ring to any extent, including, but not limited to, the following: CP 47,497, CP 55,490, CP 55,940, CP 56,667, cannabicyclohexanol.
d. Cyclopropanoylindoles—any compound structurally derived from 3-(cyclopropylmethanoyl)indole, 3-(cyclopropylmethanone)indole, 3- (cyclobutylmethanone)indole or 3-(cyclopentylmethanone)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the cyclopropyl, cyclobutyl, or cyclopentyl rings to any extent.
e. Naphthoylindoles—any compound structurally derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl group, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the naphthyl ring to any extent, including, but not limited to, the following: AM-678, AM-1220, AM-1221, AM-1235, AM-2201, AM-2232, EAM-2201, JWH-004, JWH-007, JWH-009, JWH-011, JWH-015, JWH-016, JWH-018, JWH-019, JWH-020, JWH-022, JWH-046, JWH-047, JWH-048, JWH-049, JWH-050, JWH-070, JWH-071, JWH-072, JWH-073, JWH-076, JWH-079, JWH-080, JWH-081, JWH-082, JWH-094, JWH-096, JWH-098, JWH-116, JWH-120, JWH-122, JWH-148, JWH-149, JWH-164, JWH-166, JWH-180, JWH-181, JWH-182, JWH-189, JWH-193, JWH-198, JWH-200, JWH-210, JWH-211, JWH-212, JWH-213, JWH-234, JWH-235, JWH-236, JWH-239, JWH-240, JWH-241, JWH-242, JWH-258, JWH-262, JWH-386, JWH-387, JWH-394, JWH-395, JWH-397, JWH-398, JWH-399, JWH-400, JWH-412, JWH-413, JWH-414, JWH-415, JWH-424, MAM-2201, WIN 55,212.
f. Naphthoylnaphthalenes—any compound structurally derived from naphthalene-1-yl-(naphthalene-1-yl) methanone with substitutions on either of the naphthalene rings to any extent, including, but not limited to, the following: CB-13.
g. Naphthoylpyrroles—any compound structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including, but not limited to, the following: JWH-030, JWH-031, JWH-145, JWH-146, JWH-147, JWH-150, JWH-156, JWH-243, JWH-244, JWH-245, JWH-246, JWH-292, JWH-293, JWH-307, JWH-308, JWH-309, JWH-346, JWH-348, JWH-363, JWH-364, JWH-365, JWH-367, JWH-368, JWH-369, JWH-370, JWH-371, JWH-373, JWH-392.
h. Naphthylmethylindenes—any compound containing a naphthylideneindene structure or which is structurally derived from 1-(1-naphthylmethyl)indene with substitution at the 3-position of the indene ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent, including, but not limited to, the following: JWH-171, JWH-176, JWH-220.
i. Naphthylmethylindoles—any compound structurally derived from an H-indol-3-yl-(1-naphthyl) methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including, but not limited to, the following: JWH-175, JWH-184, JWH-185, JWH-192, JWH-194, JWH-195, JWH-196, JWH-197, JWH-199.
j. Phenylacetylindoles—any compound structurally derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent, including, but not limited to, the following: Cannabipiperidiethanone, JWH-167, JWH-201, JWH-202, JWH-203, JWH-204, JWH-205, JWH-206, JWH-207, JWH-208, JWH-209, JWH-237, JWH-248, JWH-249, JWH-250, JWH-251, JWH-253, JWH-302, JWH-303, JWH-304, JWH-305, JWH-306, JWH-311, JWH-312, JWH-313, JWH-314, JWH-315, JWH-316, RCS-8.
k. Quinolinylindolecarboxylates—any compound structurally derived from quinolin-8-yl-1H-indole-3-carboxylate by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl, whether or not further substituted in the indole ring to any extent, whether or not substituted in the quinoline ring to any extent, including, but not limited to, the following: BB-22, 5-Fluoro-PB-22, PB-22.
l. Tetramethylcyclopropanoylindoles—any compound structurally derived from 3-tetramethylcyclopropanoylindole, 3-(1-tetramethylcyclopropyl)indole, 3-(2,2,3,3-tetramethylcyclopropyl)indole or 3-(2,2,3,3-tetramethylcyclopropylcarbonyl)indole with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the tetramethylcyclopropanoyl ring to any extent, including, but not limited to, the following: 5-bromo-UR-144, 5-chloro-UR-144, 5-fluoro-UR-144, A-796,260, A-834,735, AB-034, UR-144, XLR11.
m. Tetramethylcyclopropane-thiazole carboxamides—any compound structurally derived from 2,2,3,3-tetramethyl-N-(thiazol-2-ylidene)cyclopropanecarboxamide by substitution at the nitrogen atom of the thiazole ring by alkyl, haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl, whether or not further substituted in the thiazole ring to any extent, whether or not substituted in the tetramethylcyclopropyl ring to any extent, including: A-836,339.
n. Unclassified synthetic cannabinoids:
1. AM-087 (6aR,10aR)-3-(2-methyl-6-bromohex-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol.
2. AM-356 (methanandamide) (5Z,8Z,11Z,14Z)-N-[(1R)-2-hydroxy-1-methylethyl]icosa-5,8,11,14-tetraenamide; OR arachidonyl-1'-hydroxy-2'-propylamide.
3. AM-411 (6aR,10aR)-3-(1-adamantyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol AM-855 (4aR,12bR)-8-hexyl-2,5,5-trimethyl-1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol.
4. AM-905 (6aR,9R,10aR)-3-[(E)-hept-1-enyl]-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol.
5. AM-906 (6aR,9R,10aR)-3-[(Z)-hept-1-enyl]-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol.
6. AM-2389 (6aR,9R,10aR)-3-(1-hexyl-cyclobut-1-yl)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9 diol.
7. BAY 38-7271 (-)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluorobutyl-1-sulfonate.
8. CP 50,556-1 (Levonantradol) 9-hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl]acetate; OR [(6S,6aR,9R, 10aR)-9-hydroxy-6-methyl-3-[(2R)-5-ph enylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate; OR [9-hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10, 10a-octahydrophenanthridin-1-yl]acetate.
9. HU-210 (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3- (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] chromen-1-ol; OR [(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyl octan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; OR 1,1-Dimethylheptyl-11-hydroxytetrahydrocannabinol.
10. HU-211 (Dexanabinol) (6aS, 10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; OR (6aS, 10aS)-9-(hydroxymethyl)-6,6-dimethyl- 3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol.
11. HU-243 3-dimethylheptyl-11-hydroxyhexahydrocannabinol.
12. HU-308 [(91R,2R,5R)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]methanol.
13. HU-331 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione.
14. HU-336 (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione.
15. JTE-907 N-(benzol[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2-dihydroquinoline-3-carboxamide.
16. JWH-051 ((6aR,10aR)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-9-yl)methanol.
17. JWH-057 (6aR,10aR)-3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-Dibenzo[b,d]pyran.
18. JWH-133 (6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a-tetrahydro -6,6,9-trimethyl-6H-dibenzo[b,d]pyran.
19. JWH-359 (6aR,10aR)- 1-methoxy- 6,6,9-trimethyl- 3-[(2R)-1,1,2-trimethylbutyl]- 6a,7,10,10a-tetrahydrobenzo[c]chromene.
20. URB-597 [3-(3-carbamoylphenyl)phenyl]-N-cyclohexylcarbamate.
21. URB-602 [1,1'-Biphenyl]-3-yl-carbamic acid, cyclohexyl ester; OR cyclohexyl [1,1'-biphenyl]-3-ylcarbamate.
22. URB-754 6-methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one.
23. URB-937 3'-carbamoyl-6-hydroxy-[1,1'-biphenyl]-3-yl cyclohexylcarbamate.
24. WIN 55,212-2 (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-napthalenylmethanone; OR [2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[(1,2,3-de)-1,4-benzoxazin-6-yl]-1-napthalenylmethanone.
(3) Products that elicit psychoactive or psychotropic euphoric effects and are marketed under any of the following trade names, including but not limited to: K2, K3, Spice, Genie, Smoke, Potpourri, Buzz, Voodoo, Pulse, Hush, Bliss, Black Mamba, Bombay Blue, Fake Weed, Genie, Spice, Zohai, K2, K3, Smoke, Spike, Pot-Pourri, Buzz, Spice 99, Mystery, Earthquake, Stinger, Ocean Blue, Serenity, Chronic Spice, Spice Gold, Spice Silver, Skunk, Mr. Nice Guy, Mr. Happy, K3 Legal, Sence, Smoke, Chill X, Earth Impact, Galaxy Gold, Space Truckin, Solar Flare, Moon Rocks, Aroma, Scope, Sky High, Atomic, G-20, Guerrilla Warfare, Makes Scents, g-13, Tiger Shark, California Dreams, Dank, Bullet, Mind Trip, Voodoo Child, Jazz, Nightlights, Matrix, Hypnotiq, AK47, Maui Wowie, Daylights, Joker, Dead Man Walking, Brain Storm, Soul Sence, Kush, Kush Mania, Dragons Fire, Lucid, Mad Hatter, Scooby Snax, D-ZL, OMG, Demon, Barely In, Pineapple Express, Hayze, Mystery, Earthquake, Ocean Blue, Stinger, Serenity, Fake Week and Black Mamba.
(4) The term "synthetic cannabinoid" shall not include any product, substance, material, compound, mixture, or preparation that is specifically excepted by the California Uniform Controlled Substances Act ("California UCSA") (Health and Safety Code §§11000 et seq.), listed in one of the California UCSA's schedules of controlled substances (Health and Safety Code §§11053-11058), regulated by one of the California UCSA's synthetic drug laws (Health and Safety Code §§11357.5, 11375.5 and 11401), regulated by the Federal Controlled Substances Act (the "CSA") (21 USC §§ 81 et seq.) or approved by the Food and Drug Administration ("FDA").
Psychoactive stimulant effects means affecting the central nervous system or brain function to change perception, mood, consciousness, cognition or behavior in ways that are similar to the effects of cocaine, methylphenidate or amphetamines.
Psychoactive euphoric effects means affecting the central nervous system or brain function to change perception, mood, consciousness, cognition or behavior in ways that are similar to the effects of cannabis.
Sell, selling or sale means to furnish, exchange, transfer, deliver or supply for monetary gain.
Synthetic cathinone (bath salts) means any compound that mimics the effects of any federally controlled schedule I substance such as cathinone, methcathinone, MDMA, and MDEA including, but not limited to:
(1) Any quantity of a natural or synthetic material, compound, mixture, preparation, substance, and their analogue (including salts, isomers, and salts of isomers) containing substances which have a psychoactive stimulant effect on the central nervous system, including, but not limited to:
a. 2-diphenylmethylpyrrolidine.
b. 2-diphenylmethylpiperidine.
c. 2-fluoromethcathinone.
d. 3,4-dimethylmethcathinone.
e. 3-fluoromethcathinone.
f. 4-ethylmethcathinone.
g. 4-fluoromethcathinone.
h. 4-methyl-N-benzylcathinone.
i. 4-methyl-N-ethylcathinone.
j. 4-methylbuphedrone.
k. alpha-Pyrrolidinobutiophenone.
l. alpha-pyrrolidinopropiophenone.
m. alpha-Pyrrolidinopentiophenone.
n. 4-methylephedrone.
o. 2-(methylamino)-1-phenylbutan-1-one.
p. beta-Keto-N-methylbenzodioxolylpropylamine.
q. benzylpiperazine.
r. diphenyl-2-pyrrolidinyl-methanol.
s. (3-diethylamino-2,2-dimethylpropyl)-4-aminobenzoate.
t. 1-(Benzo[d][1,3]dioxol-5-yl)-2-(dimethylamino)butan-1-one.
u. dimethylethcathinone.
v. dimethylmethcathinone.
w. 2-(methylamino)-1-phenylpropan-1-one.
x. 2-ethylamino-1-phenyl-propan-1-one.
y. Ethylethcathinone.
z. Ethylmethcathinone.
aa. 3,4-methylenedioxy-N-ethylcathinone.
bb. beta-Keto-Ethylbenziodioxolylbutanamine.
cc. Fluorococaine.
dd. Fluoroethcathinone.
ee. Fluoroisocathinone.
ff. Fluoromethcathinone.
gg. 3-methoxymethcathinone.
hh. Isopentedrone.
ii. 4-methyl-alpha-pyrrolidinopropiophenone.
jj. Methylbuphedrone.
kk. 1-methyl-4-benzylpiperazine.
ll. 5,6-methylenedioxy-2-aminoindane.
mm. 6,7-methylenedioxy-2-aminotetralin.
nn. Dimethylone.
oo. Methylenedioxymethcathinone.
pp. 3,4-methylenedioxy-alpha-pyrrolidinobutiophenone.
qq. 3,4-methylenedioxy-alpha-pyrrolidinopropiophenone.
rr. 3,4-methylenedioxypyrovalerone ; mephadrone.
ss. Methylethcathinone.
tt. 4-methylmethcathinone.
uu. N,N-dimethylcathinone.
vv. 4-methoxymethcathinone.
ww. Methylmethcathinone.
xx. 3,4-methylenedioxy-N-methylcathinone.
yy. Methoxymethcathinone.
zz. 4-methoxy-alpha-pyrrolidinopropiophenone.
aaa. 4-methyl-alpha-pyrrolidinobutyrophenone.
bbb. Naphthylpyrovalerone.
ccc. NRG-2.
ddd. 2-(methylamino)-1-phenyl-1-pentanone.
eee. beta-Keto-N-methylbenzodioxolylpentanamine.
(2) Any compound (not being bupropion) structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways:
a. By substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
b. By substitution at the 3-position with an alkyl substituent;
c. By substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure.
(3) Any other crystalline or powder product that contains a synthetic compound that, when consumed, elicits psychoactive stimulant effects. These drugs are marketed under names including, but not limited to, Bliss, Blizzard, Blue Silk, Bonzai Grow, Charge Plus, Charlie, Cloud Nine (9), Euphoria, Hurricane, Ivory Snow, Ivory Wave, Lunar Wave, Ocean, Ocean Burst, Pixie Dust, Posh, Pure Ivory, Purple Wave, Red Dove, Scarface, Snow Leopard, Stardust, TranQuility, Vanilla Sky, White Dove, White Night, and White Lightning; or
(4) Any synthetic substance and its isomers with a chemical structure similar to the above listed compounds, or any chemical or natural alteration or analogue of the above listed compounds.
(5) The term "synthetic cathinone" shall not include any product, substance, material, compound, mixture or preparation that is specifically excepted by the California UCSA (Health and Safety Code §§ 11000 et seq.), listed in one of the California UCSA's schedules of controlled substances (Health and Safety Code §§ 11053-11058), regulated by one of the California UCSA's Synthetic Drug Laws (Health and Safety Code §§ 11357.5, 11375.5 and 11401), regulated by the CSA (21 USC §§ 81 et seq.) or approved by the FDA.
Synthetic drug means any synthetic cathinone, synthetic cannibanoid, novel psychoactive substance, and any other substance containing intoxicating, psychoactive or psychotropic compounds or chemicals, whether in crystalline, powder, granular, organic or liquid form, and which causes psychoactive or psychotropic stimulant or euphoric effects on the central nervous system and brain. The term "synthetic drug" shall not include any product, substance, material, compound, mixture, or preparation that is specifically excepted by the California UCSA (Health and Safety Code §§11000 et seq.), listed in one of the California UCSA's schedules of controlled substances (Health and Safety Code §§11053-11058), regulated by one of the California UCSA's synthetic drug laws (Health and Safety Code §§11357.5, 11375.5 and 11401), regulated by the CSA (21 USC §§ 81 et seq.) or approved by the FDA.
(Ord. No. 16-OR0116-1, § 1, 3-2-2016)
Source: City of Oceanside, California, City Code, Charter and Traffic Code (Municode Library, library.municode.com)URL: https://library.municode.com/ca/oceanside/codes/code_of_ordinances?nodeId=CH20OFIS_ARTVIISYDRMIMIPRCOPSSUDISADIPOUSPR_20.55.3DEFetched: 11/8/2026
